chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: hot to the touch at the injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE WARMTH (hot to the touch at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient used ice compress as treatment for the symptoms.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Rash
Clinical narrative: Viral like Symptoms; Rash on both of my calves, back side of the legs; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Viral like Symptoms) and RASH (Rash on both of my calves, back side of the legs) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0391A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Viral like Symptoms) and RASH (Rash on both of my calves, back side of the legs). On 30-Mar-2021, INFLUENZA LIKE ILLNESS (Viral like Symptoms) had resolved. At the time of the report, RASH (Rash on both of my calves, back side of the legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: Past six weeks; Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19) and PRODUCT DOSE OMISSION ISSUE (Past six weeks) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced COVID-19 (Covid-19). On 31-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Past six weeks). On 31-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Past six weeks) had resolved. At the time of the report, COVID-19 (Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow-up information received on 24-JUN-2021 contains No new information
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Paraesthesia
Clinical narrative: tingling; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling) and FATIGUE (fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PARAESTHESIA (tingling) and FATIGUE (fatigue). At the time of the report, PARAESTHESIA (tingling) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.    This case was linked to MOD-2021-063868 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fall
Clinical narrative: fell last night; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and FALL (fell last night) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced DIZZINESS (Dizziness). On 30-Mar-2021, the patient experienced FALL (fell last night). At the time of the report, DIZZINESS (Dizziness) and FALL (fell last night) outcome was unknown.            Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Nausea; headache for over a month; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache for over a month) and NAUSEA (Nausea) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced HEADACHE (headache for over a month). On an unknown date, the patient experienced NAUSEA (Nausea). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Nausea and Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache for over a month) and NAUSEA (Nausea) outcome was unknown. Not Provided          Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pruritus, Rash
Clinical narrative: My ankles and feet were extremely itchy; My ankles and feet have a rash; general achiness, that was gone by the morning 30Mar2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRURITUS (My ankles and feet were extremely itchy), RASH (My ankles and feet have a rash) and MYALGIA (general achiness, that was gone by the morning 30Mar2021) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), IRBESARTAN (AVAPRO) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced MYALGIA (general achiness, that was gone by the morning 30Mar2021). On 30-Mar-2021, the patient experienced PRURITUS (My ankles and feet were extremely itchy) and RASH (My ankles and feet have a rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash on leg and Itchy legs, at an unspecified dose and frequency. On 30-Mar-2021, MYALGIA (general achiness, that was gone by the morning 30Mar2021) had resolved. On 31-Mar-2021, PRURITUS (My ankles and feet were extremely itchy) had resolved. At the time of the report, RASH (My ankles and feet have a rash) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications included supplements.   This case was linked to MOD-2021-063849 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Dizziness, Pain in extremity
Clinical narrative: stomach upset; lightheadedness.; sore arm; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ABDOMINAL DISCOMFORT (stomach upset), DIZZINESS (lightheadedness.) and PAIN IN EXTREMITY (sore arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A210) for COVID-19 vaccination.     Concurrent medical conditions included Allergy and Depression.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIARRHOEA (diarrhea), DIZZINESS (lightheadedness.) and PAIN IN EXTREMITY (sore arm). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (stomach upset). At the time of the report, DIARRHOEA (diarrhea), ABDOMINAL DISCOMFORT (stomach upset), DIZZINESS (lightheadedness.) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include Allergy medicine and medication for depression. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Rash
Clinical narrative: tingling and a rash on their left arm; tingling and a rash on their left arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling and a rash on their left arm) and RASH (tingling and a rash on their left arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PARAESTHESIA (tingling and a rash on their left arm) and RASH (tingling and a rash on their left arm). At the time of the report, PARAESTHESIA (tingling and a rash on their left arm) and RASH (tingling and a rash on their left arm) outcome was unknown. Not Provided          Concomitant medications were not provided. Treatment information was not reported.    This case was linked to MOD-2021-063861 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swelling of the lymph nodes on his neck; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling of the lymph nodes on his neck) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swelling of the lymph nodes on his neck). At the time of the report, LYMPHADENOPATHY (swelling of the lymph nodes on his neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Dosing error (underage use); This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dosing error (underage use)) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dosing error (underage use)). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dosing error (underage use)) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: Pinkish injection site; Itching at injection site; Soreness at injection site; Redness (strip of about 3 inches down the arm and 2 inches wide) at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Pinkish injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness (strip of about 3 inches down the arm and 2 inches wide) at injection site) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE REACTION (Pinkish injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness (strip of about 3 inches down the arm and 2 inches wide) at injection site). At the time of the report, VACCINATION SITE REACTION (Pinkish injection site), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness (strip of about 3 inches down the arm and 2 inches wide) at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: TCR was received. The outcome of events were updated to recovered. It contains significant information.
Age: 55.0
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-1 test positive
Clinical narrative: Tested positive for COVID19 a week after first dose; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of SARS-COV-1 TEST POSITIVE (Tested positive for COVID19 a week after first dose) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-1 TEST POSITIVE (Tested positive for COVID19 a week after first dose). At the time of the report, SARS-COV-1 TEST POSITIVE (Tested positive for COVID19 a week after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   NO treatment information Provided No concomitant medications provided
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Gait disturbance, Headache, Myalgia
Clinical narrative: couldn't walk; jaw was shaking; sweating cold; an incredible headache; all body hurt; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (couldn't walk), TREMOR (jaw was shaking), COLD SWEAT (sweating cold), HEADACHE (an incredible headache) and MYALGIA (all body hurt) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 04-Feb-2021.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced GAIT DISTURBANCE (couldn't walk), TREMOR (jaw was shaking), COLD SWEAT (sweating cold), HEADACHE (an incredible headache), MYALGIA (all body hurt), CHILLS (chills) and PYREXIA (fever). On 05-Mar-2021, GAIT DISTURBANCE (couldn't walk), TREMOR (jaw was shaking), COLD SWEAT (sweating cold), HEADACHE (an incredible headache), MYALGIA (all body hurt), CHILLS (chills) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: couldn't walk; jaw was shaking; sweating cold; an incredible headache; all body hurt; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (couldn't walk), TREMOR (jaw was shaking), COLD SWEAT (sweating cold), HEADACHE (an incredible headache) and MYALGIA (all body hurt) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 04-Feb-2021.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced GAIT DISTURBANCE (couldn't walk), TREMOR (jaw was shaking), COLD SWEAT (sweating cold), HEADACHE (an incredible headache), MYALGIA (all body hurt), CHILLS (chills) and PYREXIA (fever). On 05-Mar-2021, GAIT DISTURBANCE (couldn't walk), TREMOR (jaw was shaking), COLD SWEAT (sweating cold), HEADACHE (an incredible headache), MYALGIA (all body hurt), CHILLS (chills) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: patient just received a third dose by error; This spontaneous case was reported by a physician and describes the occurrence of EXTRA DOSE ADMINISTERED (patient just received a third dose by error) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced EXTRA DOSE ADMINISTERED (patient just received a third dose by error). On 31-Mar-2021, EXTRA DOSE ADMINISTERED (patient just received a third dose by error) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient just received a third dose by error. All three shots were of Moderna vaccine. Third shot was received on 31-Mar-2021 at a pharmacy. Concomitant medications were not provided. Treatment information was not reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: patient will not receive second dose until after 42 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient will not receive second dose until after 42 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient will not receive second dose until after 42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient will not receive second dose until after 42 days) had resolved. Not Provided          Action taken with vaccine was not applicable. No concomitant medication was reported. No treatment information was provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Gait disturbance, Musculoskeletal chest pain, Pyrexia
Clinical narrative: rib cage is sore; fever of 104 Degrees Farenheight; joints all felt like they were on fire; I could not walk; Joints felt inflamed; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (I could not walk), ARTHRITIS (Joints felt inflamed), MUSCULOSKELETAL CHEST PAIN (rib cage is sore), PYREXIA (fever of 104 Degrees Farenheight) and ARTHRALGIA (joints all felt like they were on fire) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 008B21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC), SALBUTAMOL (ALBUTEROL HFA), EPINEPHRINE (EPIPEN), POTASSIUM CHLORIDE, HYDROCHLOROTHIAZIDE, AMLODIPINE, LOSARTAN, ISOSORBIDE MONONITRATE, ACETYLSALICYLIC ACID (ASPIRIN 81), METOPROLOL SUCCINATE, GABAPENTIN and GABAPENTIN for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced GAIT DISTURBANCE (I could not walk), ARTHRITIS (Joints felt inflamed), PYREXIA (fever of 104 Degrees Farenheight) and ARTHRALGIA (joints all felt like they were on fire). On 31-Mar-2021, the patient experienced MUSCULOSKELETAL CHEST PAIN (rib cage is sore). On 31-Mar-2021, GAIT DISTURBANCE (I could not walk), ARTHRITIS (Joints felt inflamed), PYREXIA (fever of 104 Degrees Farenheight) and ARTHRALGIA (joints all felt like they were on fire) had resolved. At the time of the report, MUSCULOSKELETAL CHEST PAIN (rib cage is sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Pyrexia: 104 (High) 104 Degrees.         Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-063833 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-063833:First dose vaccination
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Migraine, Muscle spasms
Clinical narrative: chills; sore arm; fevers; extremely tired; headache; sinus headache; muscle cramps; eye migraine; exhausted; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PAIN IN EXTREMITY (sore arm), PYREXIA (fevers), FATIGUE (extremely tired) and HEADACHE (headache) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DISULFIRAM for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), PAIN IN EXTREMITY (sore arm), PYREXIA (fevers), FATIGUE (extremely tired), HEADACHE (headache), SINUS HEADACHE (sinus headache), MUSCLE SPASMS (muscle cramps), MIGRAINE (eye migraine) and FATIGUE (exhausted). At the time of the report, CHILLS (chills), PAIN IN EXTREMITY (sore arm), PYREXIA (fevers), FATIGUE (extremely tired), HEADACHE (headache), SINUS HEADACHE (sinus headache), MUSCLE SPASMS (muscle cramps), MIGRAINE (eye migraine) and FATIGUE (exhausted) outcome was unknown.            No treatment information was provided.
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Sinus headache
Clinical narrative: chills; sore arm; fevers; extremely tired; headache; sinus headache; muscle cramps; eye migraine; exhausted; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PAIN IN EXTREMITY (sore arm), PYREXIA (fevers), FATIGUE (extremely tired) and HEADACHE (headache) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DISULFIRAM for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), PAIN IN EXTREMITY (sore arm), PYREXIA (fevers), FATIGUE (extremely tired), HEADACHE (headache), SINUS HEADACHE (sinus headache), MUSCLE SPASMS (muscle cramps), MIGRAINE (eye migraine) and FATIGUE (exhausted). At the time of the report, CHILLS (chills), PAIN IN EXTREMITY (sore arm), PYREXIA (fevers), FATIGUE (extremely tired), HEADACHE (headache), SINUS HEADACHE (sinus headache), MUSCLE SPASMS (muscle cramps), MIGRAINE (eye migraine) and FATIGUE (exhausted) outcome was unknown.            No treatment information was provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Swelling face
Clinical narrative: Face is now red; Face is now swollen; Face is now itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (Face is now red), SWELLING FACE (Face is now swollen) and PRURITUS (Face is now itchy) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL), OMEPRAZOLE and GABAPENTIN for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 31-Mar-2021, the patient experienced ERYTHEMA (Face is now red), SWELLING FACE (Face is now swollen) and PRURITUS (Face is now itchy). At the time of the report, ERYTHEMA (Face is now red), SWELLING FACE (Face is now swollen) and PRURITUS (Face is now itchy) outcome was unknown. Not Provided          No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: swelling, redness and itchiness of injection site; swelling, redness and itchiness of injection site; swelling, redness and itchiness of injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling, redness and itchiness of injection site), VACCINATION SITE ERYTHEMA (swelling, redness and itchiness of injection site) and VACCINATION SITE PRURITUS (swelling, redness and itchiness of injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, SIMVASTATIN, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling, redness and itchiness of injection site), VACCINATION SITE ERYTHEMA (swelling, redness and itchiness of injection site) and VACCINATION SITE PRURITUS (swelling, redness and itchiness of injection site). At the time of the report, VACCINATION SITE SWELLING (swelling, redness and itchiness of injection site), VACCINATION SITE ERYTHEMA (swelling, redness and itchiness of injection site) and VACCINATION SITE PRURITUS (swelling, redness and itchiness of injection site) outcome was unknown. Not Provided          No treatment information was provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Injection site pain, Nerve injury
Clinical narrative: Fingertip numbness on inoculated hand; Nerve issues are firing away; Headache; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Fingertip numbness on inoculated hand), NERVE INJURY (Nerve issues are firing away), INJECTION SITE PAIN (soreness at injection site) and HEADACHE (Headache) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included Electrocution. Concomitant products included IBUPROFEN (ADVIL 12 HOUR) and Wolfenzyme for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INJECTION SITE PAIN (soreness at injection site). On 30-Mar-2021, the patient experienced HYPOAESTHESIA (Fingertip numbness on inoculated hand), NERVE INJURY (Nerve issues are firing away) and HEADACHE (Headache). At the time of the report, HYPOAESTHESIA (Fingertip numbness on inoculated hand), NERVE INJURY (Nerve issues are firing away), INJECTION SITE PAIN (soreness at injection site) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided. Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Off label use, SARS-CoV-2 antibody test
Clinical narrative: Off label dosing frequency; Diagnosed with COVID; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (Diagnosed with COVID) and OFF LABEL USE (Off label dosing frequency) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010N20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced COVID-19 (Diagnosed with COVID). On an unknown date, the patient experienced OFF LABEL USE (Off label dosing frequency). At the time of the report, COVID-19 (Diagnosed with COVID) and OFF LABEL USE (Off label dosing frequency) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, SARS-CoV-2 antibody test: positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications include medications for anxiety and peptic ulcer disease.  Treatment medication include monoclonal antibodies   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Follow up received on 6-Apr-2021 added hcp details, concomitant medication, treatment details
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Condition aggravated, Cough, Dysphonia
Clinical narrative: cough; voice hoarseness; lack of smell; loss of taste; congestion/ cough and congestion is the wrost; headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DYSPHONIA (voice hoarseness), ANOSMIA (lack of smell), AGEUSIA (loss of taste) and CONDITION AGGRAVATED (congestion/ cough and congestion is the wrost) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced COUGH (cough), DYSPHONIA (voice hoarseness), ANOSMIA (lack of smell), AGEUSIA (loss of taste), CONDITION AGGRAVATED (congestion/ cough and congestion is the wrost) and HEADACHE (headache). At the time of the report, COUGH (cough), DYSPHONIA (voice hoarseness), ANOSMIA (lack of smell), AGEUSIA (loss of taste), CONDITION AGGRAVATED (congestion/ cough and congestion is the wrost) and HEADACHE (headache) outcome was unknown. Not Provided          No concomitant information was provided.  No treatment information was provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: cough; voice hoarseness; lack of smell; loss of taste; congestion/ cough and congestion is the wrost; headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), DYSPHONIA (voice hoarseness), ANOSMIA (lack of smell), AGEUSIA (loss of taste) and CONDITION AGGRAVATED (congestion/ cough and congestion is the wrost) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced COUGH (cough), DYSPHONIA (voice hoarseness), ANOSMIA (lack of smell), AGEUSIA (loss of taste), CONDITION AGGRAVATED (congestion/ cough and congestion is the wrost) and HEADACHE (headache). At the time of the report, COUGH (cough), DYSPHONIA (voice hoarseness), ANOSMIA (lack of smell), AGEUSIA (loss of taste), CONDITION AGGRAVATED (congestion/ cough and congestion is the wrost) and HEADACHE (headache) outcome was unknown. Not Provided          No concomitant information was provided.  No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: Rash close to the injection site; Small red area close to the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash close to the injection site) and VACCINATION SITE ERYTHEMA (Small red area close to the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash close to the injection site) and VACCINATION SITE ERYTHEMA (Small red area close to the injection site). At the time of the report, VACCINATION SITE RASH (Rash close to the injection site) and VACCINATION SITE ERYTHEMA (Small red area close to the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history was not provided.  No relevant concomitant medications were reported. The patient did not receive any treatment.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm is a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is a little sore) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     Concurrent medical conditions included No adverse event.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm is a little sore). At the time of the report, PAIN IN EXTREMITY (arm is a little sore) outcome was unknown.            Treatment information were not provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Soreness of arm). At the time of the report, PAIN IN EXTREMITY (Soreness of arm) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: follow up document received on 14-may-2021 has no new information
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on arm) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (rash on arm). At the time of the report, RASH (rash on arm) outcome was unknown. Not Provided          Reporter did not allow further contact
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Hyperhidrosis
Clinical narrative: sweating (even wet the bed); Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating (even wet the bed)) and ARTHRALGIA (Joint pain) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (sweating (even wet the bed)) and ARTHRALGIA (Joint pain). At the time of the report, HYPERHIDROSIS (sweating (even wet the bed)) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No corrective treatment was provided.   This case was linked to MOD-2021-063906 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Dizziness, Dysphonia, Muscle spasms
Clinical narrative: severe cramps; Abdominal pain; Diarrhea; Dizziness; voice is weak; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (severe cramps), ABDOMINAL PAIN (Abdominal pain), DIARRHOEA (Diarrhea), DIZZINESS (Dizziness) and DYSPHONIA (voice is weak) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced MUSCLE SPASMS (severe cramps), ABDOMINAL PAIN (Abdominal pain), DIARRHOEA (Diarrhea), DIZZINESS (Dizziness) and DYSPHONIA (voice is weak). At the time of the report, MUSCLE SPASMS (severe cramps), ABDOMINAL PAIN (Abdominal pain), DIARRHOEA (Diarrhea), DIZZINESS (Dizziness) and DYSPHONIA (voice is weak) outcome was unknown. Not Provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Injection site movement impairment, Pyrexia, Vaccination site pain
Clinical narrative: difficulty moving arm; fever 101F; headache; Vomiting; vaccination site pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain), INJECTION SITE MOVEMENT IMPAIRMENT (difficulty moving arm), PYREXIA (fever 101F), HEADACHE (headache) and VOMITING (Vomiting) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced INJECTION SITE MOVEMENT IMPAIRMENT (difficulty moving arm), PYREXIA (fever 101F) and HEADACHE (headache). On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site pain) and VOMITING (Vomiting). At the time of the report, VACCINATION SITE PAIN (vaccination site pain), INJECTION SITE MOVEMENT IMPAIRMENT (difficulty moving arm), PYREXIA (fever 101F), HEADACHE (headache) and VOMITING (Vomiting) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Body temperature: 101 (High) 101F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment details were reported.  Patient is concerned whether she may get COVID after vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow-up was received on 13-MAY-2021. Updated event (vomiting) and event outcome as recovered/resolved.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: difficulty moving arm; fever 101F; headache; Vomiting; vaccination site pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain), INJECTION SITE MOVEMENT IMPAIRMENT (difficulty moving arm), PYREXIA (fever 101F), HEADACHE (headache) and VOMITING (Vomiting) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced INJECTION SITE MOVEMENT IMPAIRMENT (difficulty moving arm), PYREXIA (fever 101F) and HEADACHE (headache). On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site pain) and VOMITING (Vomiting). At the time of the report, VACCINATION SITE PAIN (vaccination site pain), INJECTION SITE MOVEMENT IMPAIRMENT (difficulty moving arm), PYREXIA (fever 101F), HEADACHE (headache) and VOMITING (Vomiting) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Body temperature: 101 (High) 101F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment details were reported.  Patient is concerned whether she may get COVID after vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow-up was received on 13-MAY-2021. Updated event (vomiting) and event outcome as recovered/resolved.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pain
Clinical narrative: not feeling well; achiness; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well) and PAIN (achiness) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced MALAISE (not feeling well) and PAIN (achiness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (not feeling well) and PAIN (achiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication includes blood pressure medications
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Cough, Malaise, Pyrexia, SARS-CoV-2 test
Clinical narrative: had gotten sick; Positive COVID-19 test; Coughing; Temperature of 100 degrees Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (had gotten sick), SARS-COV-2 TEST POSITIVE (Positive COVID-19 test), COUGH (Coughing) and PYREXIA (Temperature of 100 degrees Fahrenheit) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced MALAISE (had gotten sick), SARS-COV-2 TEST POSITIVE (Positive COVID-19 test), COUGH (Coughing) and PYREXIA (Temperature of 100 degrees Fahrenheit). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (had gotten sick), SARS-COV-2 TEST POSITIVE (Positive COVID-19 test), COUGH (Coughing) and PYREXIA (Temperature of 100 degrees Fahrenheit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (High) 100 degree fahrenheit. On an unknown date, SARS-CoV-2 test: Positive and Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications also include Z-pack The patient was scheduled for his second dose of the vaccine on 23MAR2021-24MAR2021.